MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
You may also like
Gainers
Latest Crypto News
Expert Opinion: Stablecoins Struggle to Become Mainstream in the Currency Market
「Ultimate Shorter」 Successfully Closed Out a Significant Amount of Their BTC Short Position to Take Profit, Reducing Their Position by Approximately $30 Million
Aave is planning to sunset its deployments on zkSync, Metis, and Soneium, setting a $2 million revenue threshold for new chains.
Standard Chartered Bank is actively pursuing Blockchain Finance, believing it will replace traditional financial infrastructure
Anthropic is launching IPO preparations and may go public as early as 2026
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:[email protected]
VIP Services:[email protected]